About: Randomised trial of MNrgp120 HIV-1 vaccine in symptomless HIV-1 infection

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Randomised trial of MNrgp120 HIV-1 vaccine in symptomless HIV-1 infection Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 December 1996

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в грудні 1996 (uk) im Dezember 1996 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu n'avientu de 1996 (ast) scientific article published on 01 December 1996 (en)
publication date	wds:Q71849285-FC3BE526-B671-48ED-87E0-39D81A9281C9
publication date	1996-12-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q71849285-D2ADD309-36C5-4270-9A02-5B0D4B074F22
language of work or name	English
cites work	wds:Q71849285-033F6D86-ED0F-42D9-AFAE-691966D86A40 wds:Q71849285-13E73ED5-6F67-4292-B6B5-C20DB2285927 wds:Q71849285-1855F9FE-0E57-4688-B995-C2BD34652AC1 wds:Q71849285-2565D6FB-48FB-4317-BABD-F7191142789E wds:Q71849285-2DB681BC-23CB-40B0-BFCF-B7DCDBA3F71B wds:Q71849285-44B5041D-2850-46E3-A412-EFA713F1531C wds:Q71849285-54741209-1263-4ED1-B679-4E911A74CC81 wds:Q71849285-5E46592B-68B6-44E1-8C8E-2A4A80120005 wds:Q71849285-67B3693E-AF72-4C7F-B7CD-B415F56F5B68 wds:Q71849285-68F5B566-3EF4-49D6-A8B8-8FC2D2E5AC2E wds:Q71849285-7814ED11-91BD-4538-90D1-F4AA787F5610 wds:Q71849285-78570583-3434-44B5-89DA-127A7E28CE6A wds:Q71849285-96630DBD-9F48-49B9-9BDB-B602BA33157B wds:Q71849285-9E7A6A2A-5CAF-4404-A4AE-C960ECFB639F wds:Q71849285-BD7E9C32-3234-4FE6-BA0A-D9C43C479C80 wds:Q71849285-BE8AE85B-B053-458D-AB7F-6AD10B729A62 wds:Q71849285-D60A3C5E-EDEF-4F3A-AE07-2B04AEE48ABD wds:Q71849285-D9EB9862-0ADA-4CA2-B88C-2F4ACCC05B3B wds:Q71849285-E4D42288-C418-403B-904F-CBCF2A965AD8 wds:Q71849285-FBCBCAAF-6CC3-44B0-B6A5-5552302AAAA5 wds:Q71849285-FD7AC0FC-03EA-44F6-8035-0DCD866485ED
cites work	Adaptive evolution of human immunodeficiency virus-type 1 during the natural course of infection Summary report: workshop on the potential risks of antibody-dependent enhancement in human HIV vaccine trials Changes in plasma HIV-1 RNA and CD4+ lymphocyte counts and the risk of progression to AIDS. Veterans Affairs Cooperative Study Group on AIDS. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection Viral dynamics in human immunodeficiency virus type 1 infection HIV population dynamics in vivo: implications for genetic variation, pathogenesis, and therapy Studies in subjects with long-term nonprogressive human immunodeficiency virus infection Immunization with envelope subunit vaccine products elicits neutralizing antibodies against laboratory-adapted but not primary isolates of human immunodeficiency virus type 1. The National Institute of Allergy and Infectious Diseases AIDS Vaccine Ev Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection Virologic and immunologic characterization of long-term survivors of human immunodeficiency virus type 1 infection Effects of TH1 and TH2 cytokines on CD8+ cell response against human immunodeficiency virus: implications for long-term survival A phase I evaluation of the safety and immunogenicity of vaccination with recombinant gp160 in patients with early human immunodeficiency virus infection. Military Medical Consortium for Applied Retroviral Research A strategy for prophylactic vaccination against HIV. Zidovudine in asymptomatic human immunodeficiency virus infection. A controlled trial in persons with fewer than 500 CD4-positive cells per cubic millimeter. The AIDS Clinical Trials Group of the National Institute of Allergy and Infectious Diseases Planning a longitudinal study. II. Frequency of measurement and study duration. Quantitation of HIV-1 RNA in plasma predicts outcome after seroconversion Size and power of two-sample tests of repeated measures data HIV infection in homosexual and bisexual men 18 to 29 years of age: the San Francisco Young Men's Health Study Immunological and serological markers predictive of progression to AIDS in a cohort of HIV-infected drug users Neutralization of multiple laboratory and clinical isolates of human immunodeficiency virus type 1 (HIV-1) by antisera raised against gp120 from the MN isolate of HIV-1 Effect of immunization with inactivated gp120-depleted human immunodeficiency virus type 1 (HIV-1) immunogen on HIV-1 immunity, viral DNA, and percentage of CD4 cells
author name string	wds:Q71849285-0F5D4E17-588A-4912-B0CC-A602146F0E6B wds:Q71849285-16901F32-1C96-4670-897E-5CB99B5FE08C wds:Q71849285-65975AD9-518B-449D-80CC-DB91858C681E wds:Q71849285-7B7668EB-E802-4DD5-9561-6B387D3928D5 wds:Q71849285-7D123D46-E537-456C-8A63-6E5D3DE8DB2A wds:Q71849285-95B5F109-EB70-4043-8C43-8D08CFC60AE7 wds:Q71849285-9768EEF7-C550-4E89-8606-D1EA57BB90AB wds:Q71849285-A37A2C16-34AE-4C27-A8B8-8D22AC81D867 wds:Q71849285-BC7080F9-639B-48EB-A12B-13FF78204902 wds:Q71849285-BF191E0E-8B27-4414-B49A-1867A447F652 wds:Q71849285-DFA76F7D-FBFC-4A76-B04F-A5BE0A5C5783 wds:Q71849285-F6679B0B-7316-4BF2-8C8A-1E0CCB9DF9E2
author name string	R A Torres S G Deeks M A Conant M A Ashby B G Yangco T Twaddell W M Reiter R T Mitsuyasu J P Lavelle P G Pate M Chernow M F Giordano
rdfs:label	Randomised trial of MNrgp120 HIV-1 vaccine in symptomless HIV-1 infection (en) Randomised trial of MNrgp120 HIV-1 vaccine in symptomless HIV-1 infection (nl)
skos:prefLabel	Randomised trial of MNrgp120 HIV-1 vaccine in symptomless HIV-1 infection (en) Randomised trial of MNrgp120 HIV-1 vaccine in symptomless HIV-1 infection (nl)
name	Randomised trial of MNrgp120 HIV-1 vaccine in symptomless HIV-1 infection (en) Randomised trial of MNrgp120 HIV-1 vaccine in symptomless HIV-1 infection (nl)
author	wds:Q71849285-17C3DFEE-B547-4EA5-9817-8D0517DE1ADD
author	Joseph J Eron
title	wds:Q71849285-EF88DE75-B202-4F52-AA76-EC8B70ED16F0
title	Randomised trial of MNrgp120 HIV-1 vaccine in symptomless HIV-1 infection (en)
page(s)	wds:Q71849285-1AFC18C7-9B22-4FB0-B915-295AA8D2446F
page(s)	1547-1551
instance of	wds:Q71849285-6360569B-B27A-4184-9A72-815F1E8E1877
instance of	scholarly article
PubMed ID	wds:Q71849285-DF7BBC8A-FDEC-4F22-B445-88F07FF479ED
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/8950881
PubMed ID	8950881
published in	wds:Q71849285-377AC58F-D206-4A6E-B067-43C5940F620A
published in	The Lancet
issue	wds:Q71849285-7BB6B260-6435-4E45-BE8F-96E5966D6AFF
volume	wds:Q71849285-7216B11B-70C5-47D2-A2ED-A4FBF419E81A
issue	9041
volume	348
DOI	wds:Q71849285-4DABB13F-D22F-4275-B04E-1B362A1B98A2

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 190 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software